Chemotherapy alone may lead to a PCR negative stem cell harvest in transformed lymphoma refractory to rituximab.
Cerny
Jan
J
First Department of Internal Medicine, Institute of Biology, Charles University General Hospital, Prague, Czech Republic. jcern@hotmail.com
Slavickova
Alena
A
Krepelova
Anna
A
Trneny
Marek
M
Klener
Pavel
P
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D019008:Drug Resistance, Neoplasm; D005260:Female; D006801:Humans; D007937:Leukapheresis / Q000592:standards; D008228:Lymphoma, Non-Hodgkin / Q000175:diagnosis* / Q000628:therapy; D008875:Middle Aged; D018365:Neoplasm, Residual / Q000175:diagnosis; D016133:Polymerase Chain Reaction / Q000379:methods*; D011379:Prognosis; D000069283:Rituximab; D014178:Translocation, Genetic
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D000069283:Rituximab